| |
|
|
API PLANTS
:
|
Active Pharmaceutical
Ingredients (API's) are the building blocks in the pharmaceutical
industry. India is fast emerging as a powerhouse of API production. According to industry
reports, the upcoming and mid-cap API manufacturers in the country increasingly
favour trying the litmus test in the European capitals first before taking on the most lucrative and the most challenging US
market. As a result, all our plants are built as per regulatory requirements of USFDA and EDQM.
Indoco’s strategy is to gradually move up its value chain and “Integrate Backward” into API business and hence change its role from a
'Contract Manufacturer of Finished Dosage Forms' to be a 'Complete Solutions Provider'. This will allow Indoco to exercise complete control on the supply chain and emerge as a preferred partner for global companies.
 MULTI-TON PLANT
Indoco acquired LaNOVA Chem for strengthening its presence in the
API space and emerging as a 'Complete Solutions Provider'. The
plant is situated in the industrial area at Patalganga - near
Mumbai.
The layout and material handling is designed to meet USFDA, EDQM and
CGMP Standards.
This is a multipurpose reactor capacity from 500 Litres to 5000
Litres.
Reaction Capabilities:
- Esterification
- Oxidation
- Condensation
- Diazotisation
- Nitration
- Reduction
- Sulphonation
- Alkylation
- Hydrogenation
- Epoxidation
- Acylation
- Halogenation
- Amidation
- Hydrolysis
API KILO
MANUFACTURING FACILITY
Indoco has an API Kilo Manufacturing Facility in Rabale, which is built as per regulatory requirements of USFDA and EDQM.
The Kilo
Lab is a prototype of the API plant in the scale 1:10, that will facilitate a smooth technology transfer from R&D to plant and also service availability of small volume API’s for our Ophthalmic and Topical product ANDA's.
|
|
|
|
|
|
|
